GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of genuine question about prescription that I am slightly embarrassed to ask — 9 comments in the full submission. View in context.
65
c/glp1eu·submitted 3 months ago by u/rania_marchand

genuine question about prescription that I am slightly embarrassed to ask

PSAbranch of 6 comments

Slightly embarrassed to be asking this, but: genuine question about prescription that I am slightly embarrassed to ask. Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything. A supply notice in one member state made the front page here and had no effect…

Read the full submission and all 9 comments →

This branch

6 comments, started 3 months ago
u/ignacio_vanhecke-21 points·3 months ago

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

replysharereportpermalink
u/dario_petrescu1 point·3 months ago

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

This is the split the whole board depends on. Authorisation is European; payment is national.

replysharereportpermalink
u/dose_diary_danalog keeper1 point·3 months ago

This. The published reimbursement criteria are the document to read, and most member states do publish them.

replysharereportpermalink
u/lucia_bruun1 point·3 months ago

Which member state?

replysharereportpermalink
u/coring_the_stopper1 point·3 months ago

Right, and a shortage notice in one country tells you very little about the next one along.

replysharereportpermalink
u/dario_bakken1 point·3 months ago

Yes. Pack sizes differ enough that per-month price comparisons across borders need to be normalised before they mean anything.

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/glp1eu
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/eu_apotheke_au/nl_verzekeringu/nordic_pricingu/spain_receta
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →